PAMU
CPRX icon

Pictet Asset Management (UK)’s Catalyst Pharmaceutical CPRX Stock Holding History

Pictet Asset Management (UK)’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$74K Hold
12,800
– – ﹤0.01% 1721
2021
Q1 		$59K Hold
12,800
– – ﹤0.01% 1769
2020
Q4 		$43K Hold
12,800
– – ﹤0.01% 1739
2020
Q3 		$38K Buy
+12,800
New +$50.1K ﹤0.01% 1547

Other funds holding CPRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pictet Asset Management (UK)'s CPRX Position: Q2 2021 in Review

Pictet Asset Management (UK) held its Catalyst Pharmaceutical (CPRX) position steady in Q2 2021 at 12,800 shares worth $74K. The position accounts for ﹤0.01% of the portfolio, ranked #1721.

Pictet Asset Management (UK) first reported a position in CPRX in Q3 2020 and has held it in 4 quarters since. 139 funds tracked by Wall St. Rank hold CPRX as of Q2 2021.

  • Pictet Asset Management (UK) held 12,800 shares of Catalyst Pharmaceutical worth $74K as of Q2 2021.
  • Pictet Asset Management (UK) left its Catalyst Pharmaceutical share count unchanged in Q2 2021.
  • Catalyst Pharmaceutical made up ﹤0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #1721 holding.
  • Pictet Asset Management (UK) first reported a position in Catalyst Pharmaceutical in Q3 2020 and has held it in 4 quarters since.
  • 139 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.